Family Practice NewsFirst JAK inhibitor in psoriatic arthritis achieves results similar to adalimumabNovember 20, 2016DermatologyRheumatology
Family Practice NewsGuselkumab appears safe, effective for psoriatic arthritisNovember 18, 2016Rheumatology
Family Practice NewsVIDEO: ACR recommendations for glucocorticoid-induced osteoporosis unveiledNovember 18, 2016RheumatologyEndocrinologyClinical Guidelines
Family Practice NewsVIDEO: TNF inhibitors don’t boost cancer risk in JIANovember 17, 2016PediatricsOncologyMusculoskeletal DisordersRheumatology
Family Practice NewsVIDEO: Biologics: Proposed guideline addresses perioperative managementNovember 16, 2016RheumatologyPediatrics
Family Practice NewsContinue DMARDs, biologics in RA surgery patientsNovember 15, 2016Infectious DiseasesRheumatology
Family Practice NewsUrate-lowering therapy poses no harm to kidney functionNovember 15, 2016RheumatologyNephrology
Family Practice NewsVIDEO: Celecoxib just as safe as naproxen or ibuprofen in OA and RANovember 15, 2016CardiologyPainRheumatology
Family Practice NewsVIDEO: PRECISION exonerates celecoxib: cardiovascular risk is no worse than that of nonselective NSAIDsNovember 14, 2016RheumatologyPainCardiology
Family Practice NewsTocilizumab makes big impression in giant cell arteritis treatmentNovember 14, 2016Rheumatology
Family Practice NewsVIDEO: Cardiac inflammation present in RA patients, but resolves with RA therapyNovember 14, 2016RheumatologyCardiology
Family Practice NewsVIDEO: Allopurinol may not raise kidney disease risk in goutNovember 13, 2016Rheumatology
Family Practice NewsGenetic markers may predict response to biologics in rheumatoid arthritisNovember 13, 2016Rheumatology
Family Practice NewsOA progresses equally with new focal partial- or full-thickness cartilage damageNovember 10, 2016Rheumatology